Would AbbVie’s top execs really pull the trigger on a $30B M&A deal? Why, yes, actually
Leave it to Jami Rubin to put the Big Pharma CEO on the spot.
On Friday’s call with the top team at AbbVie …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
